CSI Market
Sign In | Register

Pharming Group N v (PHAR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PHAR Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Pharming Group N v's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		0 0 0 (Dec 31 2024)
Operating Activities
Income12.85
Depreciation & amortization11.22
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Interest Received Classified As Operating Activities2.07
Adjustments For Sharebased Payments-
Adjustments For Finance Income-
Adjustments For Finance Costs-
Adjustments For Decrease Increase In Trade And Other Receivables-
Adjustments For Increase Decrease In Trade And Other Payables-
Cash Flows From Used In Decrease Increase In Restricted Cash And Cash Equivalents Operating Activities-
Adjustments For Increase Decrease In Other Liabilities-
Increase Decrease In Working Capital-
Income Taxes Paid Refund Classified As Operating Activities-
Income taxes0.00
Losses/ -gains on Investments net2.35
Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Other Adjustments To Reconcile Profit Loss0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-14.22
Discontinued operations0.00
Net Cash flow from Operating Activities54.71
Investing Activities
Capital Expenditures0.75
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Purchase Of Investments Other Than Investments Accounted For Using Equity Method0.00
Purchase Of Intangible Assets Excluding Licenses Classified As Investing Activities-
Purchase Of Interests In Investments Accounted For Using Equity Method-
Purchase Of Intangible Assets Licenses Classified As Investing Activities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net27.75
Discontinued operations0.00
Net Cash Flow from Investing Activities26.25
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net1.50
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.50
Effect of exchange rate on cash flow82.45
Discontinued operations0.00
Free Cash Flow55.46
Total Cash Flow54.94
4 historic quarters locked

Sign in to unlock the full Pharming Group N v cash flow history.

Sign In Create Free Account

About Pharming Group N V Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001828316-26-000015

Figures are derived from filed reports and may be restated. Historical data is subject to revision.